Survival Outcomes in T3N0 versus N1 in Head and Neck Cutaneous Squamous Cell Carcinoma – Implications for Neoadjuvant Immune Checkpoint Inhibitor Immunotherapy
Hauptverfasser: | , , , , , , , , , , , |
---|---|
Format: | Artikel |
Sprache: | English |
Veröffentlicht: |
Elsevier
2024-01-01
|
Schriftenreihe: | EJC Skin Cancer |
Online Zugang: | http://www.sciencedirect.com/science/article/pii/S2772611824002362 |